Plus, oil is climbing after Trump said Russia and Saudi Arabia will work toward easing the pressure on oil by ending their price war, U.S. coronavirus cases rose past 216,000, and Luckin Coffee shares plummeted after the company disclosed that its COO had fabricated 2019 sales figures.
Read MoreBuy Target – $14.50 or better Sell Target – TradersPro Sell Signal Novavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. The company’s lead vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein recombinant nanoparticle […]
Read MorePlus, President Trump abandoned his hope of re-opening the U.S. economy by Easter as cases surge to more than 143,000, Macy’s said it is furloughing the majority of its 130,000 employees, and Johnson & Johnson said it will begin human trails on its experimental COVID-19 vaccine by September.
Read MorePlus, the $2 trillion stimulus bill has hit a snag in the House, the U.S. now has the most cases of the coronavirus in the world, and Novartis’ CEO said it’s “too soon” to say if two anti-malaria drugs will be an effective vaccine against the deadly virus.
Read MoreBuy Target – $2.25 or better Sell Target – TradersPro Sell Signal Capricor Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy, or DMD, and other medical conditions. The company’s development stage drug candidates for cardiosphere-derived cells […]
Read MorePlus, 1 month and 3 month Treasury yields slipped into negative territory this morning, Target withdrew its full-year forecast, and Nike shares are rising after the sneaker maker reported better-than-expected sales.
Read MorePlus, the market is higher on optimism that a third stimulus bill will be finalized today, Gilead Sciences’ experimental COVID-19 treatment, remdesivir, received Orphan Drug Designation from the FDA, and General Motors said it is conserving cash and drawing down $16 billion from credit lines.
Read MorePlus, Senate republicans unveiled the third coronavirus relief package, California residents are under lockdown, and JPMorgan and Walmart are giving cash bonuses to front-line employees.
Read MoreBuy Target – $35.00 or better Sell Target – TradersPro Sell Signal Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. As of February 15, 2019 the company had 11 programs in clinical trials and a total […]
Read MorePlus, stocks’ volatile week continues, oil crashed to 18-year lows, and Apple announced new products.
Read MorePlus, the Trump administration is seeking a third coronavirus stimulus package, the WHO warns that the virus can in some cases survive in the air, and Cisco said that there have been 5.5 billion meeting minutes for its Webex video conferencing platform since the start of the month.
Read MorePlus, airlines could be in danger, and Regeneron and Sanofi are soon to begin human trials on a treatment for COVID-19.
Read MorePlus, Congress and the Trump Administration are nearing a coronavirus aid package, and the Fed began buying Treasurys.
Read MorePlus, Italy announced a nation-wide lockdown in an attempt to slow the spread of the coronavirus, Saudi Arabia and Russia escalated their oil price war, and Dick’s Sporting Goods is removing guns from another 440 stores.
Read MorePlus, 30-year mortgage rates have fallen to their lowest level ever amid coronavirus fears, and an analyst says Gilead’s COVID-19 treatment only has a 50/50 chance, at best, of proving successful.
Read More